A blood clot forming in the inferior vena cava, the large vein that returns blood to your heart, accounts for 4% to 15% of all blood clot emergencies. When that clot extends into the segment closest to the right atrium of the heart, the risk of fatal complications skyrockets. In sub-Saharan Africa, this life-threatening condition remains largely invisible, not because it doesn't occur, but because the imaging tools to detect it are scarce. A recent case report from the Republic of Congo reveals how a simple bedside ultrasound technique can identify this hidden danger when MRI and CT scans aren't available .

What Is Inferior Vena Cava Thrombosis and Why Does Location Matter?

The inferior vena cava (IVC) is the main highway carrying blood from your lower body back to your heart. When a blood clot forms inside it, doctors call this IVC thrombosis. It's a type of deep vein thrombosis, the same condition that can develop in your legs after long flights or periods of immobility. What makes IVC thrombosis particularly dangerous is that clots in this vessel are closer to the heart and lungs. When a clot extends into the juxtaright atrial segment, the portion of the IVC closest to the right chamber of the heart, the risk of the clot breaking free and traveling to the lungs becomes severe .

The case that prompted this medical report involved a 66-year-old man from Congo who developed bilateral leg swelling after a prolonged car journey. Doctors discovered a blood clot measuring 20 by 9 millimeters inside a dilated IVC that extended dangerously close to his heart. What made this case particularly instructive was how it was diagnosed: using transthoracic echocardiography, a standard bedside ultrasound technique that most hospitals worldwide already possess .

How Can Bedside Ultrasound Detect a Clot Near the Heart?

In wealthy nations with advanced imaging infrastructure, doctors typically use CT venography or MRI to diagnose IVC thrombosis. These tests provide detailed cross-sectional images of blood vessels and can pinpoint clots with precision. However, in resource-limited settings across sub-Saharan Africa, these machines are often unavailable or inaccessible to patients. Transthoracic echocardiography, the same ultrasound technique used to assess heart function, has emerged as an equally effective alternative for detecting clots that extend into the juxtaright atrial region .

The procedure uses a subcostal view, meaning the ultrasound probe is placed just below the rib cage, allowing sound waves to visualize the inferior vena cava as it approaches the heart. In the case from Congo, this simple technique clearly showed the dilated vein and the thrombus within it. Remarkably, when thrombosis extends to the juxtaright atrial IVC, transthoracic echocardiography has demonstrated diagnostic accuracy equivalent to or superior to cross-sectional imaging for detecting the clot, assessing blood flow patterns, and guiding treatment decisions .

What Causes IVC Thrombosis and Who Is at Risk?

IVC thrombosis doesn't develop randomly. Several underlying conditions and circumstances create a perfect storm for clot formation. In the case from Congo, the patient had multiple risk factors working simultaneously. He had recently undergone a prolonged journey requiring him to remain seated for more than four consecutive hours, a known trigger for blood clots. Additionally, he had congestive heart failure with moderate left ventricular systolic dysfunction, a condition that impairs the heart's pumping ability and can slow blood flow. Most critically, he had suspected hepatocellular carcinoma, a liver cancer that creates a hypercoagulable state, meaning his blood was primed to clot more easily .

The combination of immobility, heart disease, and cancer created ideal conditions for thrombosis. This pattern reflects what doctors see globally: IVC thrombosis typically develops in patients with specific predisposing factors rather than appearing randomly in healthy individuals .

Steps to Recognize Warning Signs of IVC Thrombosis

• Bilateral Leg Swelling: Swelling in both legs simultaneously, rather than just one, is a hallmark sign of IVC thrombosis and distinguishes it from typical deep vein thrombosis affecting a single leg.
• Recent Prolonged Immobility: Developing leg swelling after long car rides, flights, or bed rest, especially combined with other risk factors like cancer or heart disease, warrants urgent medical evaluation.
• Abdominal or Lower Back Pain: Unexplained discomfort in the abdomen or lumbar region, particularly when accompanied by leg swelling, may indicate a clot in the IVC rather than a musculoskeletal problem.
• Heaviness or Firmness in the Legs: Patients often describe a sensation of heaviness or notice that leg swelling has a firm consistency rather than the soft pitting edema typical of other conditions.

How Is IVC Thrombosis Treated Once Detected?

Once doctors identify IVC thrombosis, the immediate goal is preventing the clot from breaking apart and traveling to the lungs, a potentially fatal event called pulmonary embolism. The patient in the Congo case was started on rivaroxaban, a direct oral anticoagulant (DOAC), at a dose of 15 milligrams twice daily for 21 days, followed by 20 milligrams once daily. This medication works by thinning the blood and preventing the clot from growing larger or new clots from forming. He also received other medications to manage his underlying conditions, including losartan for blood pressure, spironolactone for heart failure, dapagliflozin for metabolic support, rosuvastatin for cholesterol, and vitamin E as an antioxidant .

The European Society for Vascular Surgery now recommends direct oral anticoagulants as the preferred treatment for IVC thrombosis, a significant shift from older approaches. In the Congo case, anticoagulation was feasible and clinically beneficial; the patient's bilateral leg swelling resolved by day 14 of treatment. However, the clot itself persisted on follow-up imaging, which is why the patient was eventually referred to Morocco for mechanical thrombectomy, a catheter-based procedure to physically remove the clot. This intervention was not available locally, highlighting a critical gap in vascular care across much of sub-Saharan Africa .

The case underscores an important reality: while anticoagulation can prevent immediate catastrophic complications and reduce symptoms, removing the clot entirely sometimes requires specialized interventional procedures that aren't universally accessible. In resource-limited settings, doctors must balance the benefits of anticoagulation with the reality that definitive clot removal may require referral to distant centers, a journey that carries its own risks .

Why Is IVC Thrombosis Underdiagnosed in Sub-Saharan Africa?

IVC thrombosis remains largely underreported across sub-Saharan Africa, not because the condition is truly rare in the region, but because the diagnostic tools to identify it are scarce. Case series from North Africa have documented substantial numbers of IVC thrombosis cases, yet very few published observations exist from sub-Saharan Africa. This gap reflects limited access to advanced imaging modalities like MRI and CT angiography rather than a genuine absence of disease .

The Congo case demonstrates that transthoracic echocardiography can bridge this diagnostic gap. By leveraging equipment that most hospitals already possess, clinicians can identify IVC thrombosis in patients presenting with bilateral leg swelling and risk factors for blood clots. The authors of the case report concluded that echocardiographic screening should be considered in patients with lower-limb swelling and an elevated thromboembolic risk profile, particularly those with malignancy, heart disease, or recent immobility. This pragmatic approach could dramatically improve early detection and treatment initiation in regions where advanced imaging remains inaccessible .

The tragic outcome in this case, where the patient died suddenly one month after thrombectomy despite ongoing anticoagulation, underscores that IVC thrombosis remains a serious condition even with modern treatment. However, it also highlights the importance of early recognition and prompt intervention. In settings where mechanical thrombectomy is unavailable, rapid referral to centers with interventional vascular capabilities becomes essential for patients with proximal clots extending toward the heart .